Protein C, factor VII and prothrombin time as early markers of liver function recovery or failure after liver transplantation
Cross-linking of α2-antiplasmin to fibrin is a key factor in regulating blood clot lysis : species differences
Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding : relation to diagnosis and blood transfusion treatment
Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing nonanticoagulated human blood
Fibrinolytic parameters during acute haematemesis in endemic hepatosplenomegaly
Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin
Platelets contain releasable coagulation factor IX antigen
Immunofluorescent studies of tissue factor on U87MG cells: evidence for non-uniform distribution
Urinary protein C inhibitor binding region in the Bβ-chain of human fibrinogen
Evidence for thrombin binding to dermatan sulphate sites in the rabbit aorta subendothelium in vitro
The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis
The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins
Biology of factor IX
Post-receptor events associated with thrombin-induced platelet activation
Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the blood
The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction
Thrombogenic mechanisms in the human : fresh insights obtained by immunodiagnostic studies of coagulation markers
Biological effects of a S/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease
Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors
Acquired haemophilia in association with Type III von Willebrand's disease : successful treatment with high purity von Willebrand's factor and recombinant factor VIIa
Recombinant streptokinase : opportunity for an improved agent